Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Wesley R Armstrong"'
Autor:
Lisa M. Gudenkauf, Melody N. Chavez, Melinda Leigh Maconi, Carley Geiss, Ameen Seyedroudbari, Pan Thin, Aasha I. Hoogland, Kathleen Nguyen, Vishnu Murthy, Wesley R. Armstrong, Khaled Komrokji, Laura B. Oswald, Heather S.L. Jim, Ghassan El-Haddad, Wolfgang P. Fendler, Ken Herrmann, David Cella, Johannes Czernin, Michael S. Hofman, Adam P. Dicker, Jeremie Calais, Scott T. Tagawa, Brian D. Gonzalez
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 64, iss 6
The field of radionuclide therapy (RNT) for prostate cancer (PC) is growing rapidly, with recent Food and Drug Administration approval of the first 177Lu-PSMA ligand. We aimed to develop the first patient-reported outcome (PRO) measure for PC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc28323208a7a53159ef5fe209a12c7c
https://escholarship.org/uc/item/17m8q3sk
https://escholarship.org/uc/item/17m8q3sk
Autor:
Clayton P. Smith, Michael Xiang, Wesley R. Armstrong, Nicholas G. Nickols, Michael L. Steinberg, Robert E. Reiter, Matthew Rettig, Adam B. Weiner, John Shen, Luca Valle, Johannes Czernin, Jeremie Calais, Amar U. Kishan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Michael L. Steinberg, Kathleen Nguyen, Vinayak Muralidhar, Neil R. Parikh, Vincent Lok, Ting Martin Ma, Ida Sonni, Andrei Gafita, Pan Thin, David Elashoff, Johannes Czernin, Ricky Savjani, Matthew Rettig, Jesus E. Juarez, Jie Deng, Tristan Grogan, David Shabsovich, Amar U. Kishan, Patrick A. Kupelian, David D. Yang, Jeremie Calais, Nicholas G. Nickols, Carissa Chu, Felix Y. Feng, Wesley R Armstrong, Robert E. Reiter
Publikováno v:
Eur Urol Oncol
European urology oncology, vol 5, iss 1
European urology oncology, vol 5, iss 1
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is an emerging imaging modality with greater sensitivity and specificity over conventional imaging for prostate cancer (PCa) staging. Using data fro
Autor:
Staven S Raman, Ida Sonni, Ely Felker, Anthony Sisk, Wesley R Armstrong, Tristan Grogan, Jeremie Calais, Teeravut Tubtawee, Robert E. Reiter, Andrew T. Lenis, David Elashoff, Shadfar Bahri, Johannes Czernin, Matthias Eiber, Martin Allen-Auerbach, Voraparee Suvannarerg
Publikováno v:
Journal of Nuclear Medicine. 63:847-854
The role of prostate-specific membrane antigen (PSMA)-targeted PET in comparison to mpMRI in the evaluation of intraprostatic cancer foci is not well defined. The aim of our study was to compare the diagnostic performances of PSMA PET/CT, mpMRI and P
Autor:
Morand Piert, David Lin, Daniel E. Spratt, Namasvi Jariwala, Jason W.D. Hearn, Jeremie Calais, Jeffrey S. Montgomery, Thomas A. Hope, Kathleen Nguyen, Ajjai Alva, Monica Abghari-Gerst, Zachery R. Reichert, Peter J. H. Scott, Johannes Czernin, Melissa E. Rodnick, Timothy D. Johnson, Wesley R Armstrong
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 63, iss 4
We prospectively investigated the performance of the prostate-specific membrane antigen (PSMA) ligand 68Ga-PSMA-11 for detecting prostate adenocarcinoma in patients with elevated levels of prostate-specific antigen (PSA) after initial therapy. Method
Autor:
Michael S Hofman, Johannes Czernin, Clemens Kratochwil, David Elashoff, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern H. Menze, Ken Herrmann, Jeremie Calais, Hui Wang, Manuel Weber, Farid Yagubbayli, Wolfgang P. Fendler, Matthias Eiber, Ebrahim S. Delpassand, Andrei Gafita, Andrew Robertson, Wesley R Armstrong, Kathleen Nguyen, Tristan Grogan, Fernando Navarro, Raphael Zaum
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 63, iss 2
J Nucl Med
J Nucl Med
We aimed to systematically determine the impact of tumor burden on (68)Ga-prostate-specific membrane antigen-11 ((68)Ga-PSMA) PET biodistribution by the use of quantitative measurements. Methods: This international multicenter, retrospective analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b18a8a4391f84931b51e2a401daea842
https://escholarship.org/uc/item/3hp7t17v
https://escholarship.org/uc/item/3hp7t17v
Autor:
Andrei Gafita, Isabel Rauscher, Wolfgang P. Fendler, Vishnu Murthy, Wang Hui, Wesley R. Armstrong, Ken Herrmann, Wolfgang A. Weber, Jeremie Calais, Matthias Eiber, Manuel Weber, Matthias R. Benz
To compare the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, the adapted Prostate Cancer Working Group Criteria 3 (aPCWG3), the adapted Positron Emission Tomography Response Criteria in Solid Tumors (aPERCIST), the PSMA PET Progression (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d48101510b3f9826c3c09cfaf77e8c1e
Autor:
Timothy R. Donahue, Zev A. Wainberg, Mark D. Girgis, Martin Auerbach, Jeremie Calais, Ken Herrmann, Johannes Czernin, Giulia Polverari, Francesco Ceci, Wesley R Armstrong, Andrew Quon, Matthias R. Benz
The purpose of this study was to evaluate 18F-FDG PET/CT as an early and late interim imaging biomarker in patients with pancreatic ductal adenocarcinoma who undergo first-line systemic therapy. Methods: This was a prospective, single-center, single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae93533ff5c0cdb9bd3ec9caf77c0038
https://www.ncbi.nlm.nih.gov/pubmed/34272317
https://www.ncbi.nlm.nih.gov/pubmed/34272317
Autor:
Wesley R Armstrong, Johannes Czernin, Nicholas G. Nickols, David Elashoff, Jeremie Calais, Kiara M Booker, Amar U. Kishan, Wolfgang P. Fendler, Thomas A. Hope
Publikováno v:
Eur Urol Focus
European urology focus, vol 7, iss 2
European urology focus, vol 7, iss 2
The purpose of this randomized trial is to evaluate the success rate of salvage radiation therapy for recurrence of prostate cancer after radical prostatectomy, with and without planning based on prostate-specific membrane antigen positron emission t
Autor:
Wolfgang P. Fendler, Shadfar Bahri, David Ranganathan, Jeannine Gartmann, Johannes Czernin, Jeremie Calais, Rouzbeh Esfandiari, Martin Allen-Auerbach, Pan Thin, Beilei He, Kathleen Nguyen, Linda Gardner, Wesley R Armstrong, Andrew Quon, Pawan Gupta, Ken Herrmann, Magnus Dahlbom, Ebrahim S. Delpassand, Matthias Eiber
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 62, iss 10
The purpose of this analysis was to report the safety evaluation of 177Lu-PSMA-617 derived from the cohort of 64 patients exposed to 177Lu-PSMA-617 in the RESIST-PC trial NCT03042312. Methods: RESIST-PC was a prospective multicenter phase 2 trial. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f93c9519090ec3e7cb8a41201dd19de
https://escholarship.org/uc/item/3n3680n9
https://escholarship.org/uc/item/3n3680n9